PortfoliosLab logo
QSIAW vs. RXRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between QSIAW and RXRX is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.1

Performance

QSIAW vs. RXRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quantum-Si incorporated (QSIAW) and Recursion Pharmaceuticals, Inc. (RXRX). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2025FebruaryMarchApril
-86.84%
-81.68%
QSIAW
RXRX

Key characteristics

Sharpe Ratio

QSIAW:

0.12

RXRX:

-0.30

Sortino Ratio

QSIAW:

2.71

RXRX:

0.15

Omega Ratio

QSIAW:

1.33

RXRX:

1.02

Calmar Ratio

QSIAW:

0.35

RXRX:

-0.30

Martin Ratio

QSIAW:

0.60

RXRX:

-0.86

Ulcer Index

QSIAW:

57.91%

RXRX:

31.49%

Daily Std Dev

QSIAW:

293.04%

RXRX:

91.06%

Max Drawdown

QSIAW:

-98.83%

RXRX:

-90.39%

Current Drawdown

QSIAW:

-91.50%

RXRX:

-86.16%

Fundamentals

Market Cap

QSIAW:

$1.44B

RXRX:

$2.35B

PS Ratio

QSIAW:

0.00

RXRX:

39.90

PB Ratio

QSIAW:

0.00

RXRX:

2.27

Total Revenue (TTM)

QSIAW:

$2.60M

RXRX:

$45.01M

Gross Profit (TTM)

QSIAW:

$1.33M

RXRX:

$7.04M

EBITDA (TTM)

QSIAW:

-$82.67M

RXRX:

-$342.94M

Returns By Period

In the year-to-date period, QSIAW achieves a -71.99% return, which is significantly lower than RXRX's -15.38% return.


QSIAW

YTD

-71.99%

1M

-18.58%

6M

409.61%

1Y

59.14%

5Y*

N/A

10Y*

N/A

RXRX

YTD

-15.38%

1M

-1.55%

6M

-15.13%

1Y

-30.24%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

QSIAW vs. RXRX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QSIAW
The Risk-Adjusted Performance Rank of QSIAW is 7373
Overall Rank
The Sharpe Ratio Rank of QSIAW is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of QSIAW is 9393
Sortino Ratio Rank
The Omega Ratio Rank of QSIAW is 9090
Omega Ratio Rank
The Calmar Ratio Rank of QSIAW is 6868
Calmar Ratio Rank
The Martin Ratio Rank of QSIAW is 5959
Martin Ratio Rank

RXRX
The Risk-Adjusted Performance Rank of RXRX is 3737
Overall Rank
The Sharpe Ratio Rank of RXRX is 3636
Sharpe Ratio Rank
The Sortino Ratio Rank of RXRX is 4141
Sortino Ratio Rank
The Omega Ratio Rank of RXRX is 4141
Omega Ratio Rank
The Calmar Ratio Rank of RXRX is 3333
Calmar Ratio Rank
The Martin Ratio Rank of RXRX is 3232
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

QSIAW vs. RXRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Quantum-Si incorporated (QSIAW) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for QSIAW, currently valued at 0.17, compared to the broader market-2.00-1.000.001.002.003.00
QSIAW: 0.17
RXRX: -0.30
The chart of Sortino ratio for QSIAW, currently valued at 2.79, compared to the broader market-6.00-4.00-2.000.002.004.00
QSIAW: 2.79
RXRX: 0.15
The chart of Omega ratio for QSIAW, currently valued at 1.35, compared to the broader market0.501.001.502.00
QSIAW: 1.35
RXRX: 1.02
The chart of Calmar ratio for QSIAW, currently valued at 0.50, compared to the broader market0.001.002.003.004.005.00
QSIAW: 0.50
RXRX: -0.30
The chart of Martin ratio for QSIAW, currently valued at 0.87, compared to the broader market-5.000.005.0010.0015.0020.00
QSIAW: 0.87
RXRX: -0.86

The current QSIAW Sharpe Ratio is 0.12, which is higher than the RXRX Sharpe Ratio of -0.30. The chart below compares the historical Sharpe Ratios of QSIAW and RXRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50NovemberDecember2025FebruaryMarchApril
0.17
-0.30
QSIAW
RXRX

Dividends

QSIAW vs. RXRX - Dividend Comparison

Neither QSIAW nor RXRX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

QSIAW vs. RXRX - Drawdown Comparison

The maximum QSIAW drawdown since its inception was -98.83%, which is greater than RXRX's maximum drawdown of -90.39%. Use the drawdown chart below to compare losses from any high point for QSIAW and RXRX. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%NovemberDecember2025FebruaryMarchApril
-91.50%
-86.16%
QSIAW
RXRX

Volatility

QSIAW vs. RXRX - Volatility Comparison

Quantum-Si incorporated (QSIAW) has a higher volatility of 43.54% compared to Recursion Pharmaceuticals, Inc. (RXRX) at 37.83%. This indicates that QSIAW's price experiences larger fluctuations and is considered to be riskier than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%50.00%100.00%150.00%NovemberDecember2025FebruaryMarchApril
43.54%
37.83%
QSIAW
RXRX

Financials

QSIAW vs. RXRX - Financials Comparison

This section allows you to compare key financial metrics between Quantum-Si incorporated and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
1.19M
4.51M
(QSIAW) Total Revenue
(RXRX) Total Revenue
Values in USD except per share items